BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19565180)

  • 1. A chronic myeloid leukemia patient with atypical karyotype and BCR-ABL e13a3 transcript caused by complex chromosome rearrangement.
    Masuko M; Furukawa T; Abe T; Wada R; Maruyama S; Kitajima T; Shibasaki Y; Toba K; Okada M; Aizawa Y
    Int J Hematol; 2009 Sep; 90(2):230-234. PubMed ID: 19565180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E6a2 BCR-ABL fusion with BCR exon 5-deleted transcript in a Philadelphia positive CML responsive to Imatinib.
    Popovici C; Cailleres S; David M; Lafage-Pochitaloff M; Sainty D; Mozziconacci MJ
    Leuk Lymphoma; 2005 Sep; 46(9):1375-7. PubMed ID: 16109618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual disease (MRD).
    Duan MH; Li H; Cai H
    Leuk Res; 2017 Aug; 59():8-11. PubMed ID: 28527402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.
    Morel F; Bris MJ; Herry A; Calvez GL; Marion V; Abgrall JF; Berthou C; Braekeleer MD
    Eur J Haematol; 2003 Apr; 70(4):235-9. PubMed ID: 12656747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myeloid leukemia with two rare fusion gene transcripts of atypical BCR::ABL: A case report and literature review.
    Li Y; Zhang Y; Meng X; Chen S; Wang T; Zhang L; Ma X
    Medicine (Baltimore); 2024 Jan; 103(3):e36728. PubMed ID: 38241589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients.
    Bennour A; Bellâaj H; Ben Youssef Y; Elloumi M; Khelif A; Saad A; Sennana H
    J Cancer Res Clin Oncol; 2011 Sep; 137(9):1329-36. PubMed ID: 21739181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene.
    Okada M; Satake A; Kaida K; Taniguchi K; Yoshihara S; Ikegame K; Tamaki H; Soma T; Fujimori Y; Ogawa H
    Int J Hematol; 2011 Feb; 93(2):243-246. PubMed ID: 21279819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript.
    Pienkowska-Grela B; Woroniecka R; Solarska I; Kos K; Pastwińska A; Konopka L; Majewski M
    Cancer Genet Cytogenet; 2007 Apr; 174(2):111-5. PubMed ID: 17452251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1).
    Todorić-Zivanović B; Marisavljević D; Surace C; Cemerikić V; Marković O; Krtolica K; Tatomirović Z; Cikota B; Magić Z; Rocchi M
    Cancer Genet Cytogenet; 2006 Apr; 166(2):180-5. PubMed ID: 16631477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinib.
    Gadzicki D; von Neuhoff N; Steinemann D; Just M; Büsche G; Kreipe H; Wilkens L; Schlegelberger B
    Cancer Genet Cytogenet; 2005 Jun; 159(2):164-7. PubMed ID: 15899391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal chromosome aberrations in Philadelphia-negative cells from chronic myelocytic leukemia patients treated with imatinib mesylate: report of two cases.
    Herens C; Baron F; Croisiau C; Tassin F; Bours V
    Cancer Genet Cytogenet; 2003 Nov; 147(1):78-80. PubMed ID: 14580776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia.
    Hagemeijer A; Buijs A; Smit E; Janssen B; Creemers GJ; Van der Plas D; Grosveld G
    Genes Chromosomes Cancer; 1993 Dec; 8(4):237-45. PubMed ID: 7512367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Ph-negative chronic myeloid leukemia patient with a non-classical BCR-ABL rearrangement characterized by fluorescence in situ hybridization.
    Estop AM; Sherer C; Cieply K; Groft D; Burcoglu A; Jhanwar S; Thomas J
    Cancer Genet Cytogenet; 1997 Jul; 96(2):174-6. PubMed ID: 9216726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chronic myeloid leukemia case with a variant translocation t(11;22) (q23;q11.2): masked Philadelphia or simple variant translocation?
    Acar K; Uz B
    Pan Afr Med J; 2018; 30():161. PubMed ID: 30455790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases: Ph-negative and variant Ph-positive.
    Yehuda O; Abeliovich D; Ben-Neriah S; Sverdlin I; Cohen R; Varadi G; Orr R; Ashkenazi YJ; Heyd J; Lugassy G; Ben Yehuda D
    Cancer Genet Cytogenet; 1999 Oct; 114(2):100-7. PubMed ID: 10549264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.
    Bhatia R; Holtz M; Niu N; Gray R; Snyder DS; Sawyers CL; Arber DA; Slovak ML; Forman SJ
    Blood; 2003 Jun; 101(12):4701-7. PubMed ID: 12576334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Philadelphia-negative chronic myeloid leukemia with a BCR/ABL fusion gene on chromosome 9.
    Reddy KS; Grove B
    Cancer Genet Cytogenet; 1998 Nov; 107(1):48-50. PubMed ID: 9809034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of M-bcr/abl fusion by fluorescence in situ hybridization (FISH) in a case of Ph negative CML.
    Mohamed AN; Ebrahim SA; Sarkar FH; Uberti J; Wolman SR
    Cancer Genet Cytogenet; 1995 Mar; 80(1):60-2. PubMed ID: 7697634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare chronic myeloid leukemia case with Philadelphia chromosome, BCR-ABL e13a3 transcript and complex translocation involving four different chromosomes.
    Achkar WA; Wafa A; Ali BY; Manvelyan M; Liehr T
    Oncol Lett; 2010 Sep; 1(5):797-800. PubMed ID: 22966382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De nove Philadelphia chromosome-positive myelodysplastic syndromes with complex karyotype and p230
    Ma J; Guan J; Chen B
    Hematology; 2023 Dec; 28(1):2220220. PubMed ID: 37288817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.